Global SPECT Radiopharmaceuticals Market Research Report 2021

Report Description


The Global SPECT Radiopharmaceuticals Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global SPECT Radiopharmaceuticals Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.
New traders at intervals the SPECT Radiopharmaceuticals Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of SPECT Radiopharmaceuticals Market product affairs. The report is at risk of project regarding this SPECT Radiopharmaceuticals Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • GE Healthcare
  • Cardinal Health
  • Lantheus Medical Imaging
  • Bracco Imaging
  • Eczacibasi-Monrol Nuclear Products
  • IBA Molecular Imaging
  • Jubilant Life Sciences

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as SPECT Radiopharmaceuticals related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


SPECT Radiopharmaceuticals Market

SPECT Radiopharmaceuticals Market

Report Highlights:


The SPECT Radiopharmaceuticals Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The SPECT Radiopharmaceuticals Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive SPECT Radiopharmaceuticals Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of SPECT Radiopharmaceuticals Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and SPECT Radiopharmaceuticals marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the SPECT Radiopharmaceuticals market using a bottom-up approach, wherein manufacturers value data for different type (Technetium-99, Thallium-201, Gallium-67, Iodine-123, Indium-111, Other), of SPECT Radiopharmaceuticals market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

SPECT Radiopharmaceuticals Market

SPECT Radiopharmaceuticals Market

Key Target Audience:


  • SPECT Radiopharmaceuticals market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the SPECT Radiopharmaceuticals market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, SPECT Radiopharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global SPECT Radiopharmaceuticals market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Technetium-99
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • Indium-111
  • Other

By end-user also classify into, the Global SPECT Radiopharmaceuticals market:


Global SPECT Radiopharmaceuticals market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Oncology
  • Cardiology
  • Thyroid

Highlights of this 2021-2027 SPECT Radiopharmaceuticals Market Report:

  • Market dynamics, SPECT Radiopharmaceuticals economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • SPECT Radiopharmaceuticals industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide SPECT Radiopharmaceuticals Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading SPECT Radiopharmaceuticals businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the SPECT Radiopharmaceuticals market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com


TableofContents 1SPECTRadiopharmaceuticalsMarketOverview
1.1ProductOverviewandScopeofSPECTRadiopharmaceuticals
1.2SPECTRadiopharmaceuticalsSegmentbyType
1.2.1GlobalSPECTRadiopharmaceuticalsSalesGrowthRateComparisonbyType(2021-2027)
1.2.2Technetium-99
1.2.3Thallium-201
1.2.4Gallium-67
1.2.5Iodine-123
1.2.6Indium-111
1.2.7Other
1.3SPECTRadiopharmaceuticalsSegmentbyApplication
1.3.1SPECTRadiopharmaceuticalsSalesComparisonbyApplication:2021VS2027
1.3.2Oncology
1.3.3Cardiology
1.3.4Thyroid
1.4GlobalSPECTRadiopharmaceuticalsMarketSizeEstimatesandForecasts
1.4.1GlobalSPECTRadiopharmaceuticalsRevenue2016-2027
1.4.2GlobalSPECTRadiopharmaceuticalsSales2016-2027
1.4.3SPECTRadiopharmaceuticalsMarketSizebyRegion:2021Versus2027 2GlobalSPECTRadiopharmaceuticalsMarketCompetitionbyManufacturers
2.1GlobalSPECTRadiopharmaceuticalsSalesMarketSharebyManufacturers(2016-2021)
2.2GlobalSPECTRadiopharmaceuticalsRevenueSharebyManufacturers(2016-2021)
2.3GlobalSPECTRadiopharmaceuticalsAveragePricebyManufacturers(2016-2021)
2.4ManufacturersSPECTRadiopharmaceuticalsManufacturingSites,AreaServed,ProductType
2.5SPECTRadiopharmaceuticalsMarketCompetitiveSituationandTrends
2.5.1SPECTRadiopharmaceuticalsMarketConcentrationRate
2.5.2GlobalTop5andTop10PlayersMarketSharebyRevenue
2.5.3MarketSharebyCompanyType(Tier1,Tier2andTier3)
2.6ManufacturersMergers&Acquisitions,ExpansionPlans
2.7PrimaryInterviewswithKeySPECTRadiopharmaceuticalsPlayers(OpinionLeaders) 3SPECTRadiopharmaceuticalsRetrospectiveMarketScenariobyRegion
3.1GlobalSPECTRadiopharmaceuticalsRetrospectiveMarketScenarioinSalesbyRegion:2016-2021
3.2GlobalSPECTRadiopharmaceuticalsRetrospectiveMarketScenarioinRevenuebyRegion:2016-2021
3.3NorthAmericaSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.3.1NorthAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.3.2NorthAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.3.3U.S.
3.3.4Canada
3.4EuropeSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.4.1EuropeSPECTRadiopharmaceuticalsSalesbyCountry
3.4.2EuropeSPECTRadiopharmaceuticalsSalesbyCountry
3.4.3Germany
3.4.4France
3.4.5U.K.
3.4.6Italy
3.4.7Russia
3.5AsiaPacificSPECTRadiopharmaceuticalsMarketFacts&FiguresbyRegion
3.5.1AsiaPacificSPECTRadiopharmaceuticalsSalesbyRegion
3.5.2AsiaPacificSPECTRadiopharmaceuticalsSalesbyRegion
3.5.3China
3.5.4Japan
3.5.5SouthKorea
3.5.6India
3.5.7Australia
3.5.8Taiwan
3.5.9Indonesia
3.5.10Thailand
3.5.11Malaysia
3.5.12Philippines
3.5.13Vietnam
3.6LatinAmericaSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.6.1LatinAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.6.2LatinAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.6.3Mexico
3.6.3Brazil
3.6.3Argentina
3.7MiddleEastandAfricaSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.7.1MiddleEastandAfricaSPECTRadiopharmaceuticalsSalesbyCountry
3.7.2MiddleEastandAfricaSPECTRadiopharmaceuticalsSalesbyCountry
3.7.3Turkey
3.7.4SaudiArabia
3.7.5U.A.E 4GlobalSPECTRadiopharmaceuticalsHistoricMarketAnalysisbyType
4.1GlobalSPECTRadiopharmaceuticalsSalesMarketSharebyType(2016-2021)
4.2GlobalSPECTRadiopharmaceuticalsRevenueMarketSharebyType(2016-2021)
4.3GlobalSPECTRadiopharmaceuticalsPriceMarketSharebyType(2016-2021)
4.4GlobalSPECTRadiopharmaceuticalsMarketSharebyPriceTier(2016-2021):Low-End,Mid-RangeandHigh-End 5GlobalSPECTRadiopharmaceuticalsHistoricMarketAnalysisbyApplication
5.1GlobalSPECTRadiopharmaceuticalsSalesMarketSharebyApplication(2016-2021)
5.2GlobalSPECTRadiopharmaceuticalsRevenueMarketSharebyApplication(2016-2021)
5.3GlobalSPECTRadiopharmaceuticalsPricebyApplication(2016-2021) 6CompanyProfilesandKeyFiguresinSPECTRadiopharmaceuticalsBusiness
6.1GEHealthcare
6.1.1CorporationInformation
6.1.2GEHealthcareDescription,BusinessOverviewandTotalRevenue
6.1.3GEHealthcareSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.1.4GEHealthcareProductsOffered
6.1.5GEHealthcareRecentDevelopment
6.2CardinalHealth
6.2.1CardinalHealthSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.2.2CardinalHealthDescription,BusinessOverviewandTotalRevenue
6.2.3CardinalHealthSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.2.4CardinalHealthProductsOffered
6.2.5CardinalHealthRecentDevelopment
6.3LantheusMedicalImaging
6.3.1LantheusMedicalImagingSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.3.2LantheusMedicalImagingDescription,BusinessOverviewandTotalRevenue
6.3.3LantheusMedicalImagingSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.3.4LantheusMedicalImagingProductsOffered
6.3.5LantheusMedicalImagingRecentDevelopment
6.4BraccoImaging
6.4.1BraccoImagingSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.4.2BraccoImagingDescription,BusinessOverviewandTotalRevenue
6.4.3BraccoImagingSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.4.4BraccoImagingProductsOffered
6.4.5BraccoImagingRecentDevelopment
6.5Eczacibasi-MonrolNuclearProducts
6.5.1Eczacibasi-MonrolNuclearProductsSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.5.2Eczacibasi-MonrolNuclearProductsDescription,BusinessOverviewandTotalRevenue
6.5.3Eczacibasi-MonrolNuclearProductsSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.5.4Eczacibasi-MonrolNuclearProductsProductsOffered
6.5.5Eczacibasi-MonrolNuclearProductsRecentDevelopment
6.6IBAMolecularImaging
6.6.1IBAMolecularImagingSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.6.2IBAMolecularImagingDescription,BusinessOverviewandTotalRevenue
6.6.3IBAMolecularImagingSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.6.4IBAMolecularImagingProductsOffered
6.6.5IBAMolecularImagingRecentDevelopment
6.7JubilantLifeSciences
6.6.1JubilantLifeSciencesSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.6.2JubilantLifeSciencesDescription,BusinessOverviewandTotalRevenue
6.6.3JubilantLifeSciencesSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.4.4JubilantLifeSciencesProductsOffered
6.7.5JubilantLifeSciencesRecentDevelopment 7SPECTRadiopharmaceuticalsManufacturingCostAnalysis
7.1SPECTRadiopharmaceuticalsKeyRawMaterialsAnalysis
7.1.1KeyRawMaterials
7.1.2KeyRawMaterialsPriceTrend
7.1.3KeySuppliersofRawMaterials
7.2ProportionofManufacturingCostStructure
7.3ManufacturingProcessAnalysisofSPECTRadiopharmaceuticals
7.4SPECTRadiopharmaceuticalsIndustrialChainAnalysis 8MarketingChannel,DistributorsandCustomers
8.1MarketingChannel
8.2SPECTRadiopharmaceuticalsDistributorsList
8.3SPECTRadiopharmaceuticalsCustomers 9MarketDynamics 9.1MarketTrends 9.2OpportunitiesandDrivers 9.3Challenges 9.4Porter'sFiveForcesAnalysis 10GlobalMarketForecast
10.1GlobalSPECTRadiopharmaceuticalsMarketEstimatesandProjectionsbyType
10.1.1GlobalForecastedSalesofSPECTRadiopharmaceuticalsbyType(2021-2027)
10.1.2GlobalForecastedRevenueofSPECTRadiopharmaceuticalsbyType(2021-2027)
10.2SPECTRadiopharmaceuticalsMarketEstimatesandProjectionsbyApplication
10.2.1GlobalForecastedSalesofSPECTRadiopharmaceuticalsbyApplication(2021-2027)
10.2.2GlobalForecastedRevenueofSPECTRadiopharmaceuticalsbyApplication(2021-2027)
10.3SPECTRadiopharmaceuticalsMarketEstimatesandProjectionsbyRegion
10.3.1GlobalForecastedSalesofSPECTRadiopharmaceuticalsbyRegion(2021-2027)
10.3.2GlobalForecastedRevenueofSPECTRadiopharmaceuticalsbyRegion(2021-2027)
10.4NorthAmericaSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.5EuropeSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.6AsiaPacificSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.7LatinAmericaSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.8MiddleEastandAfricaSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027) 11ResearchFindingandConclusion 12MethodologyandDataSource 12.1Methodology/ResearchApproach 12.1.1ResearchPrograms/Design 12.1.2MarketSizeEstimation 12.1.3MarketBreakdownandDataTriangulation 12.2DataSource 12.2.1SecondarySources 12.2.2PrimarySources 12.3AuthorList 12.4Disclaimer


List of Tables
Table 1. Global SPECT Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2016-2027)
Table 2. Global SPECT Radiopharmaceuticals Sales (K Units) Comparison by Application: 2021 VS 2027
Table 3. Global SPECT Radiopharmaceuticals Market Size by Type (K Units) (US$ Million) (2021 VS 2027)
Table 4. Global Key SPECT Radiopharmaceuticals Manufacturers Covered in This Study
Table 5. Global SPECT Radiopharmaceuticals Sales (K Units) by Manufacturers (2016-2021)
Table 6. Global SPECT Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 7. Global SPECT Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2016-2021)
Table 8. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market SPECT Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers SPECT Radiopharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers SPECT Radiopharmaceuticals Product Types
Table 12. Global SPECT Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SPECT Radiopharmaceuticals as of 2020)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key SPECT Radiopharmaceuticals Players
Table 16. Global SPECT Radiopharmaceuticals Sales (K Units) by Region (2016-2021)
Table 17. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 18. Global SPECT Radiopharmaceuticals Revenue (Million US$) by Region (2016-2021)
Table 19. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 20. North America SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 21. North America SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 22. North America SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 23. North America SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 24. Europe SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 25. Europe SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 26. Europe SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 27. Europe SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 28. Asia Pacific SPECT Radiopharmaceuticals Sales by Region (2016-2021) (K Units)
Table 29. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 30. Asia Pacific SPECT Radiopharmaceuticals Revenue by Region (2016-2021) (US$ Million)
Table 31. Asia Pacific SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 32. Latin America SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 33. Latin America SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 34. Latin America SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 35. Latin America SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 36. Middle East and Africa SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 37. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 38. Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 39. Middle East and Africa SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 40. Global SPECT Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 41. Global SPECT Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 42. Global SPECT Radiopharmaceuticals Revenue (Million US$) by Type (2016-2021)
Table 43. Global SPECT Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 44. Global SPECT Radiopharmaceuticals Price (USD/Unit) by Type (2016-2021)
Table 45. Global SPECT Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 46. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 47. Global SPECT Radiopharmaceuticals Sales Growth Rate by Application (2016-2021)
Table 48. GE Healthcare SPECT Radiopharmaceuticals Corporation Information
Table 49. GE Healthcare Description and Business Overview
Table 50. GE Healthcare SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GE Healthcare Main Product
Table 52. GE Healthcare Recent Development
Table 53. Cardinal Health SPECT Radiopharmaceuticals Corporation Information
Table 54. Cardinal Health Corporation Information
Table 55. Cardinal Health SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Cardinal Health Main Product
Table 57. Cardinal Health Recent Development
Table 58. Lantheus Medical Imaging SPECT Radiopharmaceuticals Corporation Information
Table 59. Lantheus Medical Imaging Corporation Information
Table 60. Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Lantheus Medical Imaging Main Product
Table 62. Lantheus Medical Imaging Recent Development
Table 63. Bracco Imaging SPECT Radiopharmaceuticals Corporation Information
Table 64. Bracco Imaging Corporation Information
Table 65. Bracco Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Bracco Imaging Main Product
Table 67. Bracco Imaging Recent Development
Table 68. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Corporation Information
Table 69. Eczacibasi-Monrol Nuclear Products Corporation Information
Table 70. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Eczacibasi-Monrol Nuclear Products Main Product
Table 72. Eczacibasi-Monrol Nuclear Products Recent Development
Table 73. IBA Molecular Imaging SPECT Radiopharmaceuticals Corporation Information
Table 74. IBA Molecular Imaging Corporation Information
Table 75. IBA Molecular Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. IBA Molecular Imaging Main Product
Table 77. IBA Molecular Imaging Recent Development
Table 78. Jubilant Life Sciences SPECT Radiopharmaceuticals Corporation Information
Table 79. Jubilant Life Sciences Corporation Information
Table 80. Jubilant Life Sciences SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Jubilant Life Sciences Main Product
Table 82. Jubilant Life Sciences Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. SPECT Radiopharmaceuticals Distributors List
Table 86. SPECT Radiopharmaceuticals Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2027)
Table 89. Key Challenges
Table 90. Global SPECT Radiopharmaceuticals Sales (K Units) Forecast by Type (2021-2027)
Table 91. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2027)
Table 92. Global SPECT Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2027)
Table 93. Global SPECT Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2027)
Table 94. Global SPECT Radiopharmaceuticals Sales (K Units) Forecast by Application (2021-2027)
Table 95. Global SPECT Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2027)
Table 96. Global SPECT Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2027)
Table 97. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2027)
Table 98. Global SPECT Radiopharmaceuticals Revenue Forecast by Region (2021-2027) (US$ Million)
Table 99. Global SPECT Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2027)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of SPECT Radiopharmaceuticals
Figure 2. Global SPECT Radiopharmaceuticals Sales Market Share by Type: 2021 VS 2027
Figure 3. Technetium-99 Product Picture
Figure 4. Thallium-201 Product Picture
Figure 5. Gallium-67 Product Picture
Figure 6. Iodine-123 Product Picture
Figure 7. Indium-111 Product Picture
Figure 8. Other Product Picture
Figure 9. Global SPECT Radiopharmaceuticals Consumption Market Share by Application: 2021 VS 2027
Figure 10. Oncology
Figure 11. Cardiology
Figure 12. Thyroid
Figure 13. Global SPECT Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 14. Global SPECT Radiopharmaceuticals Sales Capacity (K Units) (2016-2027)
Figure 15. Global SPECT Radiopharmaceuticals Market Size Market Share by Region: 2021 Versus 2027
Figure 16. SPECT Radiopharmaceuticals Sales Share by Manufacturers in 2021
Figure 17. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Players: Market Share by SPECT Radiopharmaceuticals Revenue in 2020
Figure 19. SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 21. Global SPECT Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 22. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 23. Global SPECT Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 24. North America SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 25. North America SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 26. U.S. SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 27. U.S. SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 29. Canada SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Europe SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 31. Europe SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 32. Germany SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 33. Germany SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. France SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 35. France SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. U.K. SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 37. U.K. SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Italy SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 39. Italy SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Russia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 41. Russia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 43. Asia Pacific SPECT Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 44. China SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 45. China SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Japan SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 47. Japan SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. South Korea SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 49. South Korea SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. India SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 51. India SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Australia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 53. Australia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Taiwan SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 55. Taiwan SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Indonesia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 57. Indonesia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Thailand SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 59. Thailand SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Malaysia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 61. Malaysia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Philippines SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 63. Philippines SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Vietnam SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 65. Vietnam SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Latin America SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 67. Latin America SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 68. Mexico SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 69. Mexico SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Brazil SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 71. Brazil SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Argentina SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 73. Argentina SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 75. Middle East and Africa SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 76. Turkey SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 77. Turkey SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Saudi Arabia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 79. Saudi Arabia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. U.A.E SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 81. U.A.E SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Sales Market Share of SPECT Radiopharmaceuticals by Type (2016-2021)
Figure 83. Sales Market Share of SPECT Radiopharmaceuticals by Type in 2020
Figure 84. Revenue Share of SPECT Radiopharmaceuticals by Type (2016-2021)
Figure 85. Revenue Market Share of SPECT Radiopharmaceuticals by Type in 2020
Figure 86. Global SPECT Radiopharmaceuticals Sales Growth by Type (2016-2021) (K Units)
Figure 87. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 88. Global SPECT Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 89. Global Revenue Share of SPECT Radiopharmaceuticals by Application (2016-2021)
Figure 90. Global Revenue Share of SPECT Radiopharmaceuticals by Application in 2021
Figure 91. GE Healthcare Total Revenue (US$ Million): 2020 Compared with 2018
Figure 92. Cardinal Health Total Revenue (US$ Million): 2020 Compared with 2018
Figure 93. Lantheus Medical Imaging Total Revenue (US$ Million): 2020 Compared with 2018
Figure 94. Bracco Imaging Total Revenue (US$ Million): 2020 Compared with 2018
Figure 95. Eczacibasi-Monrol Nuclear Products Total Revenue (US$ Million): 2020 Compared with 2018
Figure 96. IBA Molecular Imaging Total Revenue (US$ Million): 2020 Compared with 2018
Figure 97. Jubilant Life Sciences Total Revenue (US$ Million): 2020 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of SPECT Radiopharmaceuticals
Figure 100. Manufacturing Process Analysis of SPECT Radiopharmaceuticals
Figure 101. SPECT Radiopharmaceuticals Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 106. North America SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 107. Europe SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 108. Europe SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 109. Latin America SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 110. Latin America SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 111. Middle East and Africa SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 112. Middle East and Africa SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 113. Asia Pacific SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 114. Asia Pacific SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

SPECT Radiopharmaceuticals Market Segments


SPECT Radiopharmaceuticals Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Technetium-99
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • Indium-111
  • Other

SPECT Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2021 2027)


  • Oncology
  • Cardiology
  • Thyroid

SPECT Radiopharmaceuticals Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Europe
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Asia Pacific
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Latin America
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Middle East & Africa
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

Report Description


The Global SPECT Radiopharmaceuticals Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified with the global SPECT Radiopharmaceuticals Market business, including market dynamics, segmentation, competition, and regional growth. The strategy of expansion has been adopted by key players who are increasing their production capacities to cater to the increasing demand for various application.
New traders at intervals the SPECT Radiopharmaceuticals Market face strong competition from ancient world traders as they try with technological revolutions, dependableness and commonplace of SPECT Radiopharmaceuticals Market product affairs. The report is at risk of project regarding this SPECT Radiopharmaceuticals Market evolutions and additionally the magnitude of competition, value and extra.

Leading market players: (Option 1: Free 25% Customization Profiles of 5 Additional Companies of your Choice)


This business intelligence report offers profiling of reputed companies that are operating in the market. Companies such as:

  • GE Healthcare
  • Cardinal Health
  • Lantheus Medical Imaging
  • Bracco Imaging
  • Eczacibasi-Monrol Nuclear Products
  • IBA Molecular Imaging
  • Jubilant Life Sciences

Others players have been profiled into detail so as to offer a glimpse of the market leaders. Moreover, parameters such as SPECT Radiopharmaceuticals related investment & spending and developments by major players of the market are tracked in this Global report.

Years considered for the study:


SPECT Radiopharmaceuticals Market

SPECT Radiopharmaceuticals Market

Report Highlights:


The SPECT Radiopharmaceuticals Market is widely partitioned reliant on the predictable updates in the enhancement of parameters for example, quality, trustworthiness, end customer solicitations, applications, and others. The SPECT Radiopharmaceuticals Market report contains general successful parameters, confinements, and besides has in detail illumination of the noteworthy data close by the present and future examples that may concern the advancement. The comprehensive SPECT Radiopharmaceuticals Market report elucidates within and outside representation of current advancements, parameters, and establishments.

The key regions analyzed in this study include North America, Europe, Japan, China, India, Korea, South East Asia, South America, Middle East and African countries. The leading players of SPECT Radiopharmaceuticals Market and their geographical presence across the globe are estimated based on production capacity, utilization ratio, consumer base, demand and supply scenario, profit margin and SPECT Radiopharmaceuticals marketers.

Data Lab Forecast performed primary as well as exhaustive secondary research for this study. We conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, DLF was able to include manufacturers that could not be identified due to the limitations of secondary research. We analysed product offerings, distribution channel and regional presence of all major companies in the industry.

Data Lab Forecast calculated the market size for the SPECT Radiopharmaceuticals market using a bottom-up approach, wherein manufacturers value data for different type (Technetium-99, Thallium-201, Gallium-67, Iodine-123, Indium-111, Other), of SPECT Radiopharmaceuticals market was recorded as well as forecast for the future years was made. Data Lab Forecast sourced these values from industry experts and company representatives, and externally validated through analyzing historical sales data of respective manufacturers to arrive at the overall market size. Various secondary sources such as company annual reports, white papers, investor presentations and financial reports were also studied by Data Lab Forecast.

SPECT Radiopharmaceuticals Market

SPECT Radiopharmaceuticals Market

Key Target Audience:


  • SPECT Radiopharmaceuticals market companies.
  • Research organizations and consulting companies.
  • Organizations, associations and alliances related to the SPECT Radiopharmaceuticals market industry.
  • Government bodies such as regulating authorities and policymakers.
  • Industry associations.

The study is useful in providing answers to several critical questions that are important for industry stakeholders, such as manufacturers, distributors, dealers and policymakers, about which market segments should be targeted over retail cosmetics outlets in coming years to strategize investments and capitalize on growth of the market.

Report Scope:


In this report, SPECT Radiopharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

In terms of type, the Global SPECT Radiopharmaceuticals market is segregated into:


The report includes in-detail references of all the notable product categories as well as application specifications. The product segment is described on the basis of key player development traits, sales overview, volume based returns and the like.

  • Technetium-99
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • Indium-111
  • Other

By end-user also classify into, the Global SPECT Radiopharmaceuticals market:


Global SPECT Radiopharmaceuticals market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.

  • Oncology
  • Cardiology
  • Thyroid

Highlights of this 2021-2027 SPECT Radiopharmaceuticals Market Report:

  • Market dynamics, SPECT Radiopharmaceuticals economy manufacturing, opportunities on the total pricing of this top manufacturer and improvement trend analysis;
  • SPECT Radiopharmaceuticals industry players at the general regional industry and economy synopsis;
  • Deep analysis of the most significant market players included by Worldwide SPECT Radiopharmaceuticals Market study report;
  • Understand more about the market plans that are increasingly now being adopted by leading SPECT Radiopharmaceuticals businesses;
  • Evaluation of this market character, namely market development drivers, essential challengers, inhibitors, and chances;
  • Strategically profile the key players and comprehensively analyze their growth strategies.

Competitive Landscape:

Company Profiles: Detailed analysis of the major companies presents in the SPECT Radiopharmaceuticals market.

Product Benchmarking: Benchmarking of most selling variant of all leading companies based on product type. In-depth analysis of benchmarking and recommendation on ideal product specifications.

Voice of Customer: Customer analysis by considering the major factors influencing the purchasing decision.

Available Customizations:

With the given market data, Data Lab Forecast offers customizations according to the companys specific needs. The following customization options are available for the report:

Channel Partner Analysis: Detailed list of distributors and dealers across the country.

Company Information: Detailed analysis and profiling of additional market players (up to five).

Product Information: Detailed analysis of new products in the market and their driving forces in the market.

In case you dont find what you are looking for, please get in touch with our custom research team at sales@datalabforecast.com

TableofContents 1SPECTRadiopharmaceuticalsMarketOverview
1.1ProductOverviewandScopeofSPECTRadiopharmaceuticals
1.2SPECTRadiopharmaceuticalsSegmentbyType
1.2.1GlobalSPECTRadiopharmaceuticalsSalesGrowthRateComparisonbyType(2021-2027)
1.2.2Technetium-99
1.2.3Thallium-201
1.2.4Gallium-67
1.2.5Iodine-123
1.2.6Indium-111
1.2.7Other
1.3SPECTRadiopharmaceuticalsSegmentbyApplication
1.3.1SPECTRadiopharmaceuticalsSalesComparisonbyApplication:2021VS2027
1.3.2Oncology
1.3.3Cardiology
1.3.4Thyroid
1.4GlobalSPECTRadiopharmaceuticalsMarketSizeEstimatesandForecasts
1.4.1GlobalSPECTRadiopharmaceuticalsRevenue2016-2027
1.4.2GlobalSPECTRadiopharmaceuticalsSales2016-2027
1.4.3SPECTRadiopharmaceuticalsMarketSizebyRegion:2021Versus2027 2GlobalSPECTRadiopharmaceuticalsMarketCompetitionbyManufacturers
2.1GlobalSPECTRadiopharmaceuticalsSalesMarketSharebyManufacturers(2016-2021)
2.2GlobalSPECTRadiopharmaceuticalsRevenueSharebyManufacturers(2016-2021)
2.3GlobalSPECTRadiopharmaceuticalsAveragePricebyManufacturers(2016-2021)
2.4ManufacturersSPECTRadiopharmaceuticalsManufacturingSites,AreaServed,ProductType
2.5SPECTRadiopharmaceuticalsMarketCompetitiveSituationandTrends
2.5.1SPECTRadiopharmaceuticalsMarketConcentrationRate
2.5.2GlobalTop5andTop10PlayersMarketSharebyRevenue
2.5.3MarketSharebyCompanyType(Tier1,Tier2andTier3)
2.6ManufacturersMergers&Acquisitions,ExpansionPlans
2.7PrimaryInterviewswithKeySPECTRadiopharmaceuticalsPlayers(OpinionLeaders) 3SPECTRadiopharmaceuticalsRetrospectiveMarketScenariobyRegion
3.1GlobalSPECTRadiopharmaceuticalsRetrospectiveMarketScenarioinSalesbyRegion:2016-2021
3.2GlobalSPECTRadiopharmaceuticalsRetrospectiveMarketScenarioinRevenuebyRegion:2016-2021
3.3NorthAmericaSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.3.1NorthAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.3.2NorthAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.3.3U.S.
3.3.4Canada
3.4EuropeSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.4.1EuropeSPECTRadiopharmaceuticalsSalesbyCountry
3.4.2EuropeSPECTRadiopharmaceuticalsSalesbyCountry
3.4.3Germany
3.4.4France
3.4.5U.K.
3.4.6Italy
3.4.7Russia
3.5AsiaPacificSPECTRadiopharmaceuticalsMarketFacts&FiguresbyRegion
3.5.1AsiaPacificSPECTRadiopharmaceuticalsSalesbyRegion
3.5.2AsiaPacificSPECTRadiopharmaceuticalsSalesbyRegion
3.5.3China
3.5.4Japan
3.5.5SouthKorea
3.5.6India
3.5.7Australia
3.5.8Taiwan
3.5.9Indonesia
3.5.10Thailand
3.5.11Malaysia
3.5.12Philippines
3.5.13Vietnam
3.6LatinAmericaSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.6.1LatinAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.6.2LatinAmericaSPECTRadiopharmaceuticalsSalesbyCountry
3.6.3Mexico
3.6.3Brazil
3.6.3Argentina
3.7MiddleEastandAfricaSPECTRadiopharmaceuticalsMarketFacts&FiguresbyCountry
3.7.1MiddleEastandAfricaSPECTRadiopharmaceuticalsSalesbyCountry
3.7.2MiddleEastandAfricaSPECTRadiopharmaceuticalsSalesbyCountry
3.7.3Turkey
3.7.4SaudiArabia
3.7.5U.A.E 4GlobalSPECTRadiopharmaceuticalsHistoricMarketAnalysisbyType
4.1GlobalSPECTRadiopharmaceuticalsSalesMarketSharebyType(2016-2021)
4.2GlobalSPECTRadiopharmaceuticalsRevenueMarketSharebyType(2016-2021)
4.3GlobalSPECTRadiopharmaceuticalsPriceMarketSharebyType(2016-2021)
4.4GlobalSPECTRadiopharmaceuticalsMarketSharebyPriceTier(2016-2021):Low-End,Mid-RangeandHigh-End 5GlobalSPECTRadiopharmaceuticalsHistoricMarketAnalysisbyApplication
5.1GlobalSPECTRadiopharmaceuticalsSalesMarketSharebyApplication(2016-2021)
5.2GlobalSPECTRadiopharmaceuticalsRevenueMarketSharebyApplication(2016-2021)
5.3GlobalSPECTRadiopharmaceuticalsPricebyApplication(2016-2021) 6CompanyProfilesandKeyFiguresinSPECTRadiopharmaceuticalsBusiness
6.1GEHealthcare
6.1.1CorporationInformation
6.1.2GEHealthcareDescription,BusinessOverviewandTotalRevenue
6.1.3GEHealthcareSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.1.4GEHealthcareProductsOffered
6.1.5GEHealthcareRecentDevelopment
6.2CardinalHealth
6.2.1CardinalHealthSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.2.2CardinalHealthDescription,BusinessOverviewandTotalRevenue
6.2.3CardinalHealthSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.2.4CardinalHealthProductsOffered
6.2.5CardinalHealthRecentDevelopment
6.3LantheusMedicalImaging
6.3.1LantheusMedicalImagingSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.3.2LantheusMedicalImagingDescription,BusinessOverviewandTotalRevenue
6.3.3LantheusMedicalImagingSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.3.4LantheusMedicalImagingProductsOffered
6.3.5LantheusMedicalImagingRecentDevelopment
6.4BraccoImaging
6.4.1BraccoImagingSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.4.2BraccoImagingDescription,BusinessOverviewandTotalRevenue
6.4.3BraccoImagingSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.4.4BraccoImagingProductsOffered
6.4.5BraccoImagingRecentDevelopment
6.5Eczacibasi-MonrolNuclearProducts
6.5.1Eczacibasi-MonrolNuclearProductsSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.5.2Eczacibasi-MonrolNuclearProductsDescription,BusinessOverviewandTotalRevenue
6.5.3Eczacibasi-MonrolNuclearProductsSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.5.4Eczacibasi-MonrolNuclearProductsProductsOffered
6.5.5Eczacibasi-MonrolNuclearProductsRecentDevelopment
6.6IBAMolecularImaging
6.6.1IBAMolecularImagingSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.6.2IBAMolecularImagingDescription,BusinessOverviewandTotalRevenue
6.6.3IBAMolecularImagingSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.6.4IBAMolecularImagingProductsOffered
6.6.5IBAMolecularImagingRecentDevelopment
6.7JubilantLifeSciences
6.6.1JubilantLifeSciencesSPECTRadiopharmaceuticalsProductionSitesandAreaServed
6.6.2JubilantLifeSciencesDescription,BusinessOverviewandTotalRevenue
6.6.3JubilantLifeSciencesSPECTRadiopharmaceuticalsSales,RevenueandGrossMargin(2016-2021)
6.4.4JubilantLifeSciencesProductsOffered
6.7.5JubilantLifeSciencesRecentDevelopment 7SPECTRadiopharmaceuticalsManufacturingCostAnalysis
7.1SPECTRadiopharmaceuticalsKeyRawMaterialsAnalysis
7.1.1KeyRawMaterials
7.1.2KeyRawMaterialsPriceTrend
7.1.3KeySuppliersofRawMaterials
7.2ProportionofManufacturingCostStructure
7.3ManufacturingProcessAnalysisofSPECTRadiopharmaceuticals
7.4SPECTRadiopharmaceuticalsIndustrialChainAnalysis 8MarketingChannel,DistributorsandCustomers
8.1MarketingChannel
8.2SPECTRadiopharmaceuticalsDistributorsList
8.3SPECTRadiopharmaceuticalsCustomers 9MarketDynamics 9.1MarketTrends 9.2OpportunitiesandDrivers 9.3Challenges 9.4Porter'sFiveForcesAnalysis 10GlobalMarketForecast
10.1GlobalSPECTRadiopharmaceuticalsMarketEstimatesandProjectionsbyType
10.1.1GlobalForecastedSalesofSPECTRadiopharmaceuticalsbyType(2021-2027)
10.1.2GlobalForecastedRevenueofSPECTRadiopharmaceuticalsbyType(2021-2027)
10.2SPECTRadiopharmaceuticalsMarketEstimatesandProjectionsbyApplication
10.2.1GlobalForecastedSalesofSPECTRadiopharmaceuticalsbyApplication(2021-2027)
10.2.2GlobalForecastedRevenueofSPECTRadiopharmaceuticalsbyApplication(2021-2027)
10.3SPECTRadiopharmaceuticalsMarketEstimatesandProjectionsbyRegion
10.3.1GlobalForecastedSalesofSPECTRadiopharmaceuticalsbyRegion(2021-2027)
10.3.2GlobalForecastedRevenueofSPECTRadiopharmaceuticalsbyRegion(2021-2027)
10.4NorthAmericaSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.5EuropeSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.6AsiaPacificSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.7LatinAmericaSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027)
10.8MiddleEastandAfricaSPECTRadiopharmaceuticalsEstimatesandProjections(2021-2027) 11ResearchFindingandConclusion 12MethodologyandDataSource 12.1Methodology/ResearchApproach 12.1.1ResearchPrograms/Design 12.1.2MarketSizeEstimation 12.1.3MarketBreakdownandDataTriangulation 12.2DataSource 12.2.1SecondarySources 12.2.2PrimarySources 12.3AuthorList 12.4Disclaimer

SPECT Radiopharmaceuticals Market Segments


SPECT Radiopharmaceuticals Product Type Outlook (Revenue, USD Million, 2021 2027)


  • Technetium-99
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • Indium-111
  • Other

SPECT Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2021 2027)


  • Oncology
  • Cardiology
  • Thyroid

SPECT Radiopharmaceuticals Regional Outlook (Revenue, USD Million, 2021 2027)


  • North America
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Europe
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Asia Pacific
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Latin America
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

  • Middle East & Africa
    • SPECT Radiopharmaceuticals market, By Product Type Outlook
      • Technetium-99
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Indium-111
      • Other

    • SPECT Radiopharmaceuticals market, By Application Outlook
      • Oncology
      • Cardiology
      • Thyroid

Report Content:


Qualitative Analysis


  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porters analysis
  • PESTEL Analysis
  • Value Chain Analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Overview
    • Financials
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis


  • Market size, estimates, and forecasts from 2021 - 2027
  • Market revenue estimates for product type up to 2027
  • Market revenue estimates for application type up to 2027
  • Regional market size and forecast up to 2027
  • Company financials

List of Tables
Table 1. Global SPECT Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2016-2027)
Table 2. Global SPECT Radiopharmaceuticals Sales (K Units) Comparison by Application: 2021 VS 2027
Table 3. Global SPECT Radiopharmaceuticals Market Size by Type (K Units) (US$ Million) (2021 VS 2027)
Table 4. Global Key SPECT Radiopharmaceuticals Manufacturers Covered in This Study
Table 5. Global SPECT Radiopharmaceuticals Sales (K Units) by Manufacturers (2016-2021)
Table 6. Global SPECT Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 7. Global SPECT Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2016-2021)
Table 8. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market SPECT Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers SPECT Radiopharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers SPECT Radiopharmaceuticals Product Types
Table 12. Global SPECT Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SPECT Radiopharmaceuticals as of 2020)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key SPECT Radiopharmaceuticals Players
Table 16. Global SPECT Radiopharmaceuticals Sales (K Units) by Region (2016-2021)
Table 17. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 18. Global SPECT Radiopharmaceuticals Revenue (Million US$) by Region (2016-2021)
Table 19. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 20. North America SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 21. North America SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 22. North America SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 23. North America SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 24. Europe SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 25. Europe SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 26. Europe SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 27. Europe SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 28. Asia Pacific SPECT Radiopharmaceuticals Sales by Region (2016-2021) (K Units)
Table 29. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 30. Asia Pacific SPECT Radiopharmaceuticals Revenue by Region (2016-2021) (US$ Million)
Table 31. Asia Pacific SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 32. Latin America SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 33. Latin America SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 34. Latin America SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 35. Latin America SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 36. Middle East and Africa SPECT Radiopharmaceuticals Sales by Country (2016-2021) (K Units)
Table 37. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 38. Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country (2016-2021) (US$ Million)
Table 39. Middle East and Africa SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 40. Global SPECT Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 41. Global SPECT Radiopharmaceuticals Sales Share by Type (2016-2021)
Table 42. Global SPECT Radiopharmaceuticals Revenue (Million US$) by Type (2016-2021)
Table 43. Global SPECT Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 44. Global SPECT Radiopharmaceuticals Price (USD/Unit) by Type (2016-2021)
Table 45. Global SPECT Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 46. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 47. Global SPECT Radiopharmaceuticals Sales Growth Rate by Application (2016-2021)
Table 48. GE Healthcare SPECT Radiopharmaceuticals Corporation Information
Table 49. GE Healthcare Description and Business Overview
Table 50. GE Healthcare SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GE Healthcare Main Product
Table 52. GE Healthcare Recent Development
Table 53. Cardinal Health SPECT Radiopharmaceuticals Corporation Information
Table 54. Cardinal Health Corporation Information
Table 55. Cardinal Health SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Cardinal Health Main Product
Table 57. Cardinal Health Recent Development
Table 58. Lantheus Medical Imaging SPECT Radiopharmaceuticals Corporation Information
Table 59. Lantheus Medical Imaging Corporation Information
Table 60. Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Lantheus Medical Imaging Main Product
Table 62. Lantheus Medical Imaging Recent Development
Table 63. Bracco Imaging SPECT Radiopharmaceuticals Corporation Information
Table 64. Bracco Imaging Corporation Information
Table 65. Bracco Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Bracco Imaging Main Product
Table 67. Bracco Imaging Recent Development
Table 68. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Corporation Information
Table 69. Eczacibasi-Monrol Nuclear Products Corporation Information
Table 70. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Eczacibasi-Monrol Nuclear Products Main Product
Table 72. Eczacibasi-Monrol Nuclear Products Recent Development
Table 73. IBA Molecular Imaging SPECT Radiopharmaceuticals Corporation Information
Table 74. IBA Molecular Imaging Corporation Information
Table 75. IBA Molecular Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. IBA Molecular Imaging Main Product
Table 77. IBA Molecular Imaging Recent Development
Table 78. Jubilant Life Sciences SPECT Radiopharmaceuticals Corporation Information
Table 79. Jubilant Life Sciences Corporation Information
Table 80. Jubilant Life Sciences SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Jubilant Life Sciences Main Product
Table 82. Jubilant Life Sciences Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. SPECT Radiopharmaceuticals Distributors List
Table 86. SPECT Radiopharmaceuticals Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2027)
Table 89. Key Challenges
Table 90. Global SPECT Radiopharmaceuticals Sales (K Units) Forecast by Type (2021-2027)
Table 91. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2027)
Table 92. Global SPECT Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2027)
Table 93. Global SPECT Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2027)
Table 94. Global SPECT Radiopharmaceuticals Sales (K Units) Forecast by Application (2021-2027)
Table 95. Global SPECT Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2027)
Table 96. Global SPECT Radiopharmaceuticals Sales (K Units) Forecast by Region (2021-2027)
Table 97. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2027)
Table 98. Global SPECT Radiopharmaceuticals Revenue Forecast by Region (2021-2027) (US$ Million)
Table 99. Global SPECT Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2027)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of SPECT Radiopharmaceuticals
Figure 2. Global SPECT Radiopharmaceuticals Sales Market Share by Type: 2021 VS 2027
Figure 3. Technetium-99 Product Picture
Figure 4. Thallium-201 Product Picture
Figure 5. Gallium-67 Product Picture
Figure 6. Iodine-123 Product Picture
Figure 7. Indium-111 Product Picture
Figure 8. Other Product Picture
Figure 9. Global SPECT Radiopharmaceuticals Consumption Market Share by Application: 2021 VS 2027
Figure 10. Oncology
Figure 11. Cardiology
Figure 12. Thyroid
Figure 13. Global SPECT Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 14. Global SPECT Radiopharmaceuticals Sales Capacity (K Units) (2016-2027)
Figure 15. Global SPECT Radiopharmaceuticals Market Size Market Share by Region: 2021 Versus 2027
Figure 16. SPECT Radiopharmaceuticals Sales Share by Manufacturers in 2021
Figure 17. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Players: Market Share by SPECT Radiopharmaceuticals Revenue in 2020
Figure 19. SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 21. Global SPECT Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 22. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 23. Global SPECT Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 24. North America SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 25. North America SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 26. U.S. SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 27. U.S. SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Canada SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 29. Canada SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Europe SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 31. Europe SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 32. Germany SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 33. Germany SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. France SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 35. France SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. U.K. SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 37. U.K. SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Italy SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 39. Italy SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Russia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 41. Russia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 43. Asia Pacific SPECT Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 44. China SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 45. China SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Japan SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 47. Japan SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. South Korea SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 49. South Korea SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. India SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 51. India SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. Australia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 53. Australia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Taiwan SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 55. Taiwan SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Indonesia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 57. Indonesia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Thailand SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 59. Thailand SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Malaysia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 61. Malaysia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Philippines SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 63. Philippines SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Vietnam SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 65. Vietnam SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. Latin America SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 67. Latin America SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 68. Mexico SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 69. Mexico SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Brazil SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 71. Brazil SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Argentina SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 73. Argentina SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Country in 2020
Figure 75. Middle East and Africa SPECT Radiopharmaceuticals Revenue Market Share by Country in 2020
Figure 76. Turkey SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 77. Turkey SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Saudi Arabia SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 79. Saudi Arabia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. U.A.E SPECT Radiopharmaceuticals Sales Growth Rate (2016-2021) (K Units)
Figure 81. U.A.E SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Sales Market Share of SPECT Radiopharmaceuticals by Type (2016-2021)
Figure 83. Sales Market Share of SPECT Radiopharmaceuticals by Type in 2020
Figure 84. Revenue Share of SPECT Radiopharmaceuticals by Type (2016-2021)
Figure 85. Revenue Market Share of SPECT Radiopharmaceuticals by Type in 2020
Figure 86. Global SPECT Radiopharmaceuticals Sales Growth by Type (2016-2021) (K Units)
Figure 87. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Figure 88. Global SPECT Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 89. Global Revenue Share of SPECT Radiopharmaceuticals by Application (2016-2021)
Figure 90. Global Revenue Share of SPECT Radiopharmaceuticals by Application in 2021
Figure 91. GE Healthcare Total Revenue (US$ Million): 2020 Compared with 2018
Figure 92. Cardinal Health Total Revenue (US$ Million): 2020 Compared with 2018
Figure 93. Lantheus Medical Imaging Total Revenue (US$ Million): 2020 Compared with 2018
Figure 94. Bracco Imaging Total Revenue (US$ Million): 2020 Compared with 2018
Figure 95. Eczacibasi-Monrol Nuclear Products Total Revenue (US$ Million): 2020 Compared with 2018
Figure 96. IBA Molecular Imaging Total Revenue (US$ Million): 2020 Compared with 2018
Figure 97. Jubilant Life Sciences Total Revenue (US$ Million): 2020 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of SPECT Radiopharmaceuticals
Figure 100. Manufacturing Process Analysis of SPECT Radiopharmaceuticals
Figure 101. SPECT Radiopharmaceuticals Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 106. North America SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 107. Europe SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 108. Europe SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 109. Latin America SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 110. Latin America SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 111. Middle East and Africa SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 112. Middle East and Africa SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 113. Asia Pacific SPECT Radiopharmaceuticals Sales (K Units) and Growth Rate Forecast (2021-2027)
Figure 114. Asia Pacific SPECT Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2027)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed
Choose License Type
  • $4250  
  • $5850  
  • $7250  

Secure Payment


img1

Related Reports

Anti-Allergic Drugs Market

Report Description The Global Anti-Allergic Drugs Market Report provides Insightful information to t

Read More

Cannabis Pharmaceutical Market

Key Industry Insights This report is an extensive study that includes a detailed overview of the Can

Read More

Vaccine Packaging Market

Report Description According to the new market study, we provide a comprehensive and in-depth analys

Read More